作者
Tamara N Bongers, Moniek PM de Maat, Mary-Lou PJ van Goor, Vinod Bhagwanbali, Huub HDM van Vliet, Encarna B Gómez García, Diederik WJ Dippel, Frank WG Leebeek
发表日期
2006/11/1
期刊
Stroke
卷号
37
期号
11
页码范围
2672-2677
出版商
Lippincott Williams & Wilkins
简介
Background and Purpose— Elevated von Willebrand factor (vWF) concentrations are associated with an increased risk of ischemic heart disease. Several factors influence vWF antigen levels and activity, including blood group, genetic variability, acute-phase response, and proteolysis by A Disintegrin and Metalloprotease with ThromboSpondin motif (ADAMTS13), a determinant of proteolytic cleavage of vWF. We assessed how these factors affect the relation between vWF and the occurrence of stroke to understand the underlying mechanism.
Methods— In a case-control study of 124 first-ever ischemic stroke patients and 125 age- and sex-matched controls, we studied vWF antigen (vWF:Ag), vWF ristocetin cofactor activity (vWF:RCo), ADAMTS13 activity, the −1793C/G polymorphism in the vWF gene, and C-reactive protein.
Results— vWF antigen and activity levels were significantly higher in cases than in …
引用总数
2007200820092010201120122013201420152016201720182019202020212022202320249152017182017152813241715231417105